| HIT: linking herbal active ingredients to targets H Ye, L Ye, H Kang, D Zhang, L Tao, K Tang, X Liu, R Zhu, Q Liu, ... Nucleic acids research 39 (suppl_1), D1055-D1059, 2010 | 345 | 2010 |
| Construction of drug network based on side effects and its application for drug repositioning H Ye, Q Liu, J Wei PloS one 9 (2), e87864, 2014 | 132 | 2014 |
| Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition H Ye, K Wang, M Wang, R Liu, H Song, N Li, Q Lu, W Zhang, Y Du, ... Biomaterials 206, 1-12, 2019 | 131 | 2019 |
| An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition K Wang, H Ye, X Zhang, X Wang, B Yang, C Luo, Z Zhao, J Zhao, Q Lu, ... Biomaterials 257, 120224, 2020 | 106 | 2020 |
| Nanosponges of circulating tumor-derived exosomes for breast cancer metastasis inhibition H Ye, K Wang, Q Lu, J Zhao, M Wang, Q Kan, H Zhang, Y Wang, Z He, ... Biomaterials 242, 119932, 2020 | 100 | 2020 |
| Drug repositioning through network pharmacology HY Jia Wei, Kailin Tang, Ritchie Feuers, Huixiao Hong Current Topics in Medicinal Chemistry 16 (30), 2016 | 84 | 2016 |
| Estrogenic Activity Data Extraction and in Silico Prediction Show the Endocrine Disruption Potential of Bisphenol A Replacement Compounds HW Ng, M Shu, H Luo, H Ye, W Ge, R Perkins, W Tong, H Hong Chemical research in toxicology 28 (9), 1784-1795, 2015 | 81 | 2015 |
| Machine learning methods for predicting HLA-peptide binding activity H Luo, H Ye, HW Ng, L Shi, W Tong, DL Mendrick, H Hong Bioinformatics and biology insights 9, BBI. S29466, 2015 | 79 | 2015 |
| Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival SK Qin, Q Li, J Ming Xu, J Liang, Y Cheng, Y Fan, J Jiang, H Ye, H Tao, ... Cancer Science 111 (11), 4218-4231, 2020 | 59 | 2020 |
| Development and validation of decision forest model for estrogen receptor binding prediction of chemicals using large data sets HW Ng, SW Doughty, H Luo, H Ye, W Ge, W Tong, H Hong Chemical research in toxicology 28 (12), 2343-2351, 2015 | 56 | 2015 |
| Assessment of tumor mutation burden calculation from gene panel sequencing data Z Xu, J Dai, D Wang, H Lu, H Dai, H Ye, J Gu, S Chen, B Huang OncoTargets and therapy, 3401-3409, 2019 | 51 | 2019 |
| Erythrocyte membrane-camouflaged carrier-free nanoassembly of FRET photosensitizer pairs with high therapeutic efficiency and high security for programmed cancer synergistic … X Zhang, J Xiong, K Wang, H Yu, B Sun, H Ye, Z Zhao, N Wang, Y Wang, ... Bioactive materials 6 (8), 2291-2302, 2021 | 50 | 2021 |
| Alignment of short reads: a crucial step for application of next-generation sequencing data in precision medicine H Ye, J Meehan, W Tong, H Hong Pharmaceutics 7 (4), 523-541, 2015 | 50 | 2015 |
| Exploring the mechanism of flavonoids through systematic bioinformatics analysis T Qiu, D Wu, LL Yang, H Ye, Q Wang, Z Cao, K Tang Frontiers in pharmacology 9, 918, 2018 | 47 | 2018 |
| Towards a bioinformatics analysis of anti-Alzheimer’s herbal medicines from a target network perspective Y Sun, R Zhu, H Ye, K Tang, J Zhao, Y Chen, Q Liu, Z Cao Briefings in bioinformatics 14 (3), 327-343, 2013 | 47 | 2013 |
| A 6-year study of complicated urinary tract infections in southern China: prevalence, antibiotic resistance, clinical and economic outcomes X Li, Y Chen, W Gao, H Ye, Z Shen, Z Wen, J Wei Therapeutics and clinical risk management, 1479-1487, 2017 | 46 | 2017 |
| Self-strengthened oxidation-responsive bioactivating prodrug nanosystem with sequential and synergistically facilitated drug release for treatment of breast cancer K Wang, B Yang, H Ye, X Zhang, H Song, X Wang, N Li, L Wei, Y Wang, ... ACS applied materials & interfaces 11 (21), 18914-18922, 2019 | 42 | 2019 |
| Bioengineered platelets combining chemotherapy and immunotherapy for postsurgical melanoma treatment: internal core-loaded doxorubicin and external surface-anchored anti-PD-L1 … Q Lu, H Ye, K Wang, J Zhao, H Wang, J Song, X Fan, Y Lu, L Cao, B Wan, ... Nano letters 22 (7), 3141-3150, 2022 | 38 | 2022 |
| Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer L Cai, H Bai, J Duan, Z Wang, S Gao, D Wang, S Wang, J Jiang, J Han, ... Journal for Immunotherapy of Cancer 7, 1-11, 2019 | 36 | 2019 |
| DPDR-CPI, a server that predicts drug positioning and drug repositioning via chemical-protein interactome H Luo, P Zhang, XH Cao, D Du, H Ye, H Huang, C Li, S Qin, C Wan, L Shi, ... Scientific reports 6 (1), 35996, 2016 | 31 | 2016 |
